Kingfisher plc. - Coronavirus (COVID-19) Company Impact
Summary The Coronavirus (COVID-19) company impact report analyses how the pandemic will impact Kingfisher plc.’s performance.
The Kingfisher plc. group is expected to have a challenging 2020 due to prolonged store closures and a softening in demand in Europe.
The group’s improved sales in May 2020 and a rise in online sales in April 2020 provided some positivity
Scope - Kingfisher is expected to have a challenging 2020, with revenue forecast to decline 12.6% to US$14.1 billion.
- A concentrated geographical spread, together with the lack of a diverse business portfolio, will lead to significant business losses for Kingfisher plc.
Reasons to Buy - Use our revised 2020 forecast for Kingfisher plc. to understand how it will perform this year.
- Use our charts to review how Kingfisher plc.’s sales are split by region globally and how these regions have been impacted by COVID-19.
- Use our in-depth analysis to review how Kingfisher plc. has responded to COVID-19 and how this will affect its performance.
Our reports have been used by over 10K customers, including:
With a population of more than 1 billion, China is the world’s largest country and therefore also its single largest potential market for goods and services. In the past ten years, China has led all major world economies in the average rate of growth in real GDP, total health expenditures, and government health expenditures. As an in vitro...
In Vitro Diagnostics
Point Of Care Testing
Infectious Disease
Pathology
Laboratory
China
Health Expenditure
Urban Population
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.
